Merck MRK
NYSE MRK
$154.18 +5.19 (+3.48%)
As of: Aug 21, 2026 · 11:00 AM EDT

Merck (MRK) EBT Margin (2009 - 2026)

Merck (MRK) posted quarterly EBT Margin of 21.49% for Q1 2026, down 5950.0% year-over-year from 0.37% in Q1 2025, and down 203.06% quarter-over-quarter from 20.85% in Q4 2025.

Merck (MRK) EBT Margin (2009 - 2026) Analysis & Trends

Merck (MRK) has reported EBT Margin for 18 consecutive years, with 21.49% the latest figure, recorded in Q1 2026.

  • In Q1 2026, EBT Margin fell 5950.0% year-over-year to 21.49%; the TTM figure through Mar 2026 stood at 17.74% (down 1382.0% YoY), while the FY2025 annual figure was 32.41%, up 134.0% from the prior year.
  • EBT Margin declined to 21.49% in Q1 2026 per MRK's latest filing, from 20.85% in the prior quarter.
  • Across five years, EBT Margin topped out at 39.04% in Q3 2025 and bottomed at 35.48% in Q2 2023.
  • Historically, EBT Margin has averaged 20.83% across 5 years, with a median of 26.69% in 2024.
  • Annual changes were most pronounced in 2023 — EBT Margin plunged 6623 bps — and 2024, when it jumped 7276 bps.
  • Merck's EBT Margin stood at 25.4% in 2022, then plunged by 155 bps to 13.98% in 2023, then surged by 291 bps to 26.69% in 2024, then slipped by 22 bps to 20.85% in 2025, then slumped by 203 bps to 21.49% in 2026.
  • Business Quant data shows MRK's EBT Margin at 21.49% in Q1 2026, 20.85% in Q4 2025, and 39.04% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Johnson & Johnson 652.19 Bn 631.43 Bn 17.26 Bn 26.66%
2 AbbVie 470.70 Bn 464.13 Bn 12.70 Bn 25.18%
3 Merck 379.55 Bn 372.41 Bn 12.21 Bn -4.11%
4 Novartis Ag 302.93 Bn 295.24 Bn 11.24 Bn 29.63%
5 Astrazeneca 257.73 Bn 252.83 Bn 12.86 Bn 18.19%
6 Amgen 236.90 Bn 222.91 Bn 7.24 Bn 27.53%
7 Gilead Sciences 182.87 Bn 179.69 Bn 6.22 Bn -131.41%
8 Pfizer 161.71 Bn 150.01 Bn 10.94 Bn -4.34%
9 Gsk 105.60 Bn 101.43 Bn 8.24 Bn 4.21%
10 Sanofi 55.13 Bn 47.75 Bn 10.79 Bn 127.52%

Historic Data

Download Data
DateValue
Jun 30, 2026 -4.11%
Mar 31, 2026 -21.49%
Dec 31, 2025 20.85%
Sep 30, 2025 39.04%
Jun 30, 2025 31.63%
Mar 31, 2025 38.01%
Dec 31, 2024 26.69%
Sep 30, 2024 24.55%
Jun 30, 2024 37.28%
Mar 31, 2024 35.94%
Dec 31, 2023 -13.98%
Sep 30, 2023 35.21%
Jun 30, 2023 -35.48%
Mar 31, 2023 25.20%
Dec 31, 2022 25.40%
Sep 30, 2022 23.95%
Jun 30, 2022 30.75%
Mar 31, 2022 30.57%
Dec 31, 2021 28.91%
Sep 30, 2021 40.03%